The Pharma QC Column: OROSIL C18

June 1, 2008
Orochem Technologies, Inc.

The Application Notebook

Volume 0, Issue 0

The QC for the pharmaceutical industry is based on methods developed on a variety of columns. At Orochem, we have attempted to address method development utilizing unique chemistries such as the OROSIL C18 to analyze a wide range of acidic, basic, and neutral compounds. Data is presented on a few representative compounds and unique separation criteria with their associated chromatograms.

The QC for the pharmaceutical industry is based on methods developed on a variety of columns. At Orochem, we have attempted to address method development utilizing unique chemistries such as the OROSIL C18 to analyze a wide range of acidic, basic, and neutral compounds. Data is presented on a few representative compounds and unique separation criteria with their associated chromatograms.

Figure 1

Conclusion

We have successfully developed methods for more than 25 analytes with the Orosil C18 column. The OROSIL C18 chemistry provides a unique platform for the analytes currently targeted by the pharma industry towards major diseased states.

Orochem Technologies Inc,

Eisenhower Ln South, Lombard, IL 60148

Tel: 630-916-0225

www.orochem.com